These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32876720)

  • 41. Exploring the role of physical activity and exercise for managing vascular comorbidities in people with multiple sclerosis: A scoping review.
    Ewanchuk BW; Gharagozloo M; Peelen E; Pilutti LA
    Mult Scler Relat Disord; 2018 Nov; 26():19-32. PubMed ID: 30216755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship of cognitive impairment with neurological and psychiatric variables in multiple sclerosis patients.
    Karadayi H; Arisoy O; Altunrende B; Boztas MH; Sercan M
    Int J Psychiatry Clin Pract; 2014 Jan; 18(1):45-51. PubMed ID: 24047424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of Mood or Anxiety Disorders in Children of Parents with Multiple Sclerosis.
    Razaz N; Tremlett H; Boyce T; Guhn M; Marrie RA; Joseph KS
    Paediatr Perinat Epidemiol; 2016 Jul; 30(4):356-66. PubMed ID: 27009813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The occurrence of comorbidities with affective and anxiety disorders among older people with intellectual disability compared with the general population: a register study.
    El Mrayyan N; Eberhard J; Ahlström G
    BMC Psychiatry; 2019 Jun; 19(1):166. PubMed ID: 31159756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Associations among comorbid anxiety, psychiatric symptomatology, and diabetic control in a population with serious mental illness and diabetes: Findings from an interventional randomized controlled trial.
    Aftab A; Bhat C; Gunzler D; Cassidy K; Thomas C; McCormick R; Dawson NV; Sajatovic M
    Int J Psychiatry Med; 2018 May; 53(3):126-140. PubMed ID: 29280685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. InMS: Chronic insomnia disorder in multiple sclerosis - a Portuguese multicentre study on prevalence, subtypes, associated factors and impact on quality of life.
    Viana P; Rodrigues E; Fernandes C; Matas A; Barreto R; Mendonça M; Peralta R; Geraldes R
    Mult Scler Relat Disord; 2015 Sep; 4(5):477-483. PubMed ID: 26346798
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comorbid mood and anxiety disorders and severity of posttraumatic stress disorder symptoms in treatment-seeking veterans.
    Knowles KA; Sripada RK; Defever M; Rauch SAM
    Psychol Trauma; 2019 May; 11(4):451-458. PubMed ID: 29963890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anxiety in Argentinian patients with multiple sclerosis: Prevalence and associated factors.
    Chertcoff A; Curbelo MC; Bauer J; Ferrandina F; Martinez A; Steinberg J; Carrá A
    Mult Scler Relat Disord; 2020 Jun; 41():102042. PubMed ID: 32163755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data.
    Marrie RA; Walld R; Bolton JM; Sareen J; Walker JR; Patten SB; Singer A; Lix LM; Hitchon CA; El-Gabalawy R; Katz A; Fisk JD; Bernstein CN;
    BMC Res Notes; 2017 Nov; 10(1):619. PubMed ID: 29178935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis.
    Brown RF; Valpiani EM; Tennant CC; Dunn SM; Sharrock M; Hodgkinson S; Pollard JD
    Psychol Psychother; 2009 Mar; 82(Pt 1):41-56. PubMed ID: 18727845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of psychiatric and extraintestinal comorbidity on quality of life and bowel symptom burden in functional GI disorders.
    Vu J; Kushnir V; Cassell B; Gyawali CP; Sayuk GS
    Neurogastroenterol Motil; 2014 Sep; 26(9):1323-32. PubMed ID: 25070610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data.
    Maric GD; Pekmezovic TD; Mesaros ST; Tamas OS; Ivanovic JB; Martinovic VN; Andabaka MM; Jovanovic AL; Veselinovic ND; Kisic-Tepavcevic DB; Drulovic JS
    Neurol Sci; 2021 May; 42(5):1887-1893. PubMed ID: 32964347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fatigue and its association with sleep disorders, depressive symptoms and anxiety in patients with multiple sclerosis.
    Labuz-Roszak B; Kubicka-Bączyk K; Pierzchała K; Machowska-Majchrzak A; Skrzypek M
    Neurol Neurochir Pol; 2012; 46(4):309-17. PubMed ID: 23023429
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comorbidity in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing.
    Teesson M; Slade T; Mills K
    Aust N Z J Psychiatry; 2009 Jul; 43(7):606-14. PubMed ID: 19530017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis.
    Zhang T; Tremlett H; Leung S; Zhu F; Kingwell E; Fisk JD; Bhan V; Campbell TL; Stadnyk K; Yu BN; Marrie RA;
    Neurology; 2016 Apr; 86(14):1287-1295. PubMed ID: 26944268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Affectivity and alexithymia: two dimensions explicative of the relationship between anxiety and depressive symptoms].
    Bonnet A; Bréjard V; Pasquier A; Pedinielli JL
    Encephale; 2012 Jun; 38(3):187-93. PubMed ID: 22726406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple sclerosis is associated with higher comorbidity and health care resource use: A population-based, case-control study in a western Mediterranean region.
    Cárdenas-Robledo S; Otero-Romero S; Passarell-Bacardit MA; Carbonell-Mirabent P; Sastre-Garriga J; Montalban X; Tintoré M
    Eur J Neurol; 2021 Dec; 28(12):4124-4134. PubMed ID: 34293826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosis.
    Marrie RA; Patten SB; Greenfield J; Svenson LW; Jette N; Tremlett H; Wolfson C; Warren S; Profetto-McGrath J; Fisk JD; ; Blanchard J; Caetano P; Elliott L; Yu BN; Bhan V; Svenson L
    Brain Behav; 2016 Sep; 6(9):e00493. PubMed ID: 27688933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences in the burden of psychiatric comorbidity in MS vs the general population.
    Marrie RA; Fisk JD; Tremlett H; Wolfson C; Warren S; Tennakoon A; Leung S; Patten SB;
    Neurology; 2015 Dec; 85(22):1972-9. PubMed ID: 26519542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.